Posted by Michael Wonder on 08 Jun 2017
Biosimilar drugs offer promise for drug price savings, but risks remain
5 June 2017 - The issue of prescription drug prices continues to top the list of public concerns about health costs, and Congress and the administration are floating possible policy solutions.
Solutions to this complex problem will be most effective if they are targeted and geared toward encouraging rather than undermining competition and innovation in the vibrant 21st century life sciences industry.
